Money flow confirms this, Institutional money mangers confirm this. Point and figure chart confirm this. Fair value confirm this. Price target Dec. 2013 $ 3.20.
Another one to consider PVHO$ .08 Read the latest news then go to the Company home page listen to the Video from the CEO and Sales for cast. One yr. Price target June 14 2014 $ .50 500% return
Volume and money flow is proving out RAD as the better buy. RAD price is still a buy out target. Institutions have increase there position and upgrades are confirming this plus the additional analyst are coming aboard.
Buy out price target $ 7
Excuse me, there, Mr. Taxidriver, but Rite Aid has about $3 Billion in NEGATIVE net asset value. They have humongous debt and a terrible track record of same-store sales growth and lack of operating profit.
RAD looks more like a candidate for demise than a rival to Walgreens or even CVS or Walmart.
The last time I was in a Rite Aid, the pharmacist was wearing a turban and looked like he might have just sabotaged the Boston Marathon. Up in Wisconsin, we don't like terrorists very much. Do you?
And why do you say RAD is a "great American company" when most of its Rx's come from India, Israel and Turkey and almost all its front end garbage comes from China and other 3rd world countries?
Earnings out on RAD thurs. June 20 Fix your account buy RAD before earings. Rad recently upped there guidance. Plus point and fingure chart has raised price target $ 7.25. New coverage and plus up grades.
RAD is a turn around story and still 1/10 peers valuations. New price target Dec 2013 $ 5.25
Actually Wag isn't a better company, it proved that with the express scripts debacle and then trying to fix the mistake by running off to Europe to sell lipstick and perfume. Rite Aid is a great american company and is proving it by being innovative and focused like a laser on implementing its excellent game plan. Look for $10 easy in the next year. Go RAD!!!!